The MYD88 L265P mutation detected in one of the SMZL cases occurs at a residue in the TIR domain that is important for protein complex assembling and supports cell survival by activating NF-κB and JAK-STAT signaling pathways [14]. The gene discussed is NFKB1; the disease is splenic marginal zone lymphoma.